Akari Therapeutics Plc (AKTX) › Net IncomeAkari Therapeutics Plc (AKTX) — Net IncomeAnnual figures by fiscal year, from SEC filings.2006: -$1.77M2007: -$3.13M2008: -$1.44M2009: -$1.01M2010: -$675.0K2011: -$2.12M2012: -$4.27M2013: -$3.62M2014: -$1.95M2015: -$45.32M2016: -$18.14M2017: -$35.40M2018: -$20.50M2019: -$16.85M2020: -$17.08M2021: -$17.42M2022: -$17.75M2023: -$10.01M2024: -$19.79M2025: -$17.30M-$17.30M2006Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$17.30M+12.6%2024-$19.79M-97.8%2023-$10.01M+43.6%2022-$17.75M-1.9%2021-$17.42M-2.0%2020-$17.08M-1.4%2019-$16.85M+17.8%2018-$20.50M+42.1%2017-$35.40M-95.1%2016-$18.14M+60.0%2015-$45.32M-2226.9%2014-$1.95M+46.2%2013-$3.62M+15.2%2012-$4.27M-101.4%2011-$2.12M-213.9%2010-$675.0K+33.3%2009-$1.01M+29.5%2008-$1.44M+54.2%2007-$3.13M-77.0%2006-$1.77M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share